Epidemiology of triglycerides: A view from Framingham

      This paper is only available as a PDF. To read, Please Download here.


      New analyses from the Framingham Heart Study are presented showing that men and women who have high triglyceride levels (>1.7 mmol/liter) and a low high-density lipoprotein (HDL) level (<1.03 mmol/liter) run a significantly higher rate of coronary artery disease and can be identified, and that this risk group (high triglyceride-low HDL) is, independently of the major risk factors (including low HDL), related to occurrence of coronary artery disease. Further, this trait appears to be common in our society, producing twice as many cases of coronary artery disease during the 14 years of the Framingham study as the next highest disease-producing lipid abnormality. This trait of high triglyceride-low HDL is associated in the medical literature with increased insulin resistance, higher blood sugars (within the normal range), higher uric add levels, hypertension, and centrally mediated obesity. Because total cholesterol in people with these traits may be less than or just slightly greater than 5.2 mmol/liter, they are missed or neglected by most cholesterol screening programs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Austin MA
        Plasma triglyceride and coronary heart disease.
        Arterioscler Thromb. 1991; 11: 2-14
        • Hulley SB
        • Rosenman RH
        • Bawol RD
        • Brand RJ
        Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease.
        N Engl J Med. 1980; 302: 1383-1389
        • Abbott RD
        • Garrison RJ
        • Wilson PW
        • Castelli WP
        Coronary heart disease risk: the importance of joint relationships among cholesterol levels in individual lipoprotein classes.
        Prev Med. 1982; 11: 131-141
        • Gofman JW
        • The Joint Technical Group of the Committee of Lipoproteins and Atherosclerosis
        Evaluation of serum lipoproteins and cholesterol measurements as predictors of clinical complications of atherosclerosis.
        Circulation. 1956; 14: 691-741
        • Lipid Research Clinics Program
        Manual of Laboratory Operations. Vol. I. Lipid and lipoprotein analysis.
        in: Department of Health Education and Welfare Publication (NIH) 75-628. National Institutes of Health, Bethesda1976
        • Fredrickson DS
        • Levy RI
        • Lees RS
        Fat transport in lipoproteins: an integrated approach to mechanisms and disorders.
        N Engl J Med. 1967; 276: 34-44
        • Fredrickson DS
        • Levy RI
        • Lees RS
        Fat transport in lipoproteins: an integrated approach to mechanisms and disorders.
        N Engl J Med. 1967; 276: 94-103
        • Fredrickson DS
        • Levy RI
        • Lees RS
        Fat transport in lipoproteins: an integrated approach to mechanisms and disorders.
        N Engl J Med. 1967; 276: 148-156
        • Fredrickson DS
        • Levy RI
        • Lees RS
        Fat transport in lipoproteins: an integrated approach to mechanisms and disorders.
        N Engl J Med. 1967; 276: 215-224
        • Fredrickson DS
        • Levy RI
        • Lees RS
        Fat transport in lipoproteins: an integrated approach to mechanisms and disorders.
        N Engl J Med. 1967; 276: 273-281
        • Abell LL
        • Levy BB
        • Brodie BB
        • Kendall FE
        A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.
        J Biol Chem. 1952; 195: 357-366
        • Cupples LA
        • D'agostino RB
        • Kiely D
        Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements.
        in: The Framingham study: an epidemiological investigation of cardiovascular disease. 30-year follow-up. National Heart, Lung and Blood Institute. ed. 6. US Department of Health and Human Services, Public Health Service, National Institutes of Health Publication 87-2703. National Technical Information Service, Springfield VA1987
        • Cox DR
        Regression model and life-tables (with discussion).
        J R Statist Soc. 1972; B-34: 187-220
        • SAS Institute Inc
        ed. 6. SAS Technical Report P-217, SAS/STAT Software: the PHREG Procedure; Version 6. SAS Institute Inc, Cary, NC1991
        • Assmann G
        • Schulte H
        Triglycerides and atherosclerosis: results from the Prospective Cardiovascular Munster Study.
        Atheroscler Rev. 1991; 22: 51-57
        • Goldstein JL
        • Schrott HG
        • Hazzard WR
        • Bierman EL
        • Motulsky AG
        Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.
        J Clin Invest. 1973; 52: 1544-1568
        • Manninen V
        • Tenkanen L
        • Koskinen P
        • Huttunen JK
        • Manttari M
        • Heinonen OP
        • Frick MH
        Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
        Circulation. 1992; 85: 37-45
        • Steiner G
        Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications.
        Am J Cardiol. 1986; 57: 27G-30G
        • Reaven GM
        Role of insulin resistance in human disease.
        Diabetes. 1988; 37: 1595-1607
        • Williams RR
        • Hunt SC
        • Hopkins PN
        • Stults BM
        • Wu LL
        • Hasstedt SJ
        • Barlow GK
        • Stephenson SH
        • Lalouel JM
        • Kuida H
        Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension.
        JAMA. 1988; 259: 3579-3586
        • Kaplan N
        The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.
        Arch Intern Med. 1989; 149: 1514-1520
        • Castelli WP
        Cholesterol and lipids in the risk of coronary artery disease—the Framingham Heart Study.
        Can J Cardiol. 1988; 4: 5A-10A
        • Poapst M
        • Reardon M
        • Steiner G
        Relative contribution of triglyceride-rich lipoprotein particle size and number to plasma triglyceride concentration.
        Arteriosclerosis. 1985; 5: 381-390
        • Havel RJ
        Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis.
        Med Clin North Am. 1982; 66: 441-454
        • Mahley RW
        Type III hyperlipoproteinemia (dysbetalipoproteinemia): a genetic disorder associated with premature atherosclerosis.
        in: Steiner G Shafrir E Primary hyperlipoproteinemias. McGraw-Hill, New York1991: 261-270
        • Sniderman A
        • Shapiro S
        • Marpole D
        • Skinner B
        • Teng B
        • Kwiterovich Jr, PO
        The association of coronary atherosclerosis and hyperapobetalipoproteinemia (increased protein but normal cholesterol content in human plasma low density lipoprotein).
        in: ed. 6. Proc Natl Acad Sci USA. 77. 1980: 604-608
        • Austin MA
        • Breslow JL
        • Hennekens CH
        • Buring JE
        • Willett WC
        • Krauss RM
        Low density lipoprotein subclass patterns and risk of myocardial infarction.
        JAMA. 1988; 260: 1917-1920
        • Austin MA
        • King MC
        • Vranizan KM
        • Krauss RM
        Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk.
        Circulation. 1990; 82: 495-506
        • Goldstein JL
        • Ho YK
        • Brown MS
        • Innerarity TL
        • Mahley RW
        Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins.
        J Biol Chem. 1980; 255: 1839-1848
        • Mahley RW
        • Innerarity TL
        • Brown MS
        Cholesteryl ester synthesis in macrophages: stimulation by β-very low-density lipoproteins from cholesterolfed animals of several species.
        J Lipid Res. 1980; 21: 970-980
        • Steinberg D
        • Witztum JL
        Lipoproteins and atherogenesis.
        JAMA. 1990; 264: 3047-3052
        • Schonfeld G
        Changes in the composition of very low density lipoprotein during carbohydrate induction in man.
        J Lab Clin Med. 1970; 75: 206-211
        • Ruderman NB
        • Jones AL
        • Krauss RM
        A biochemical and morphologic study of very low density lipoproteins in carbohydrate induced hypertriglyceridemia.
        J Clin Invest. 1971; 50: 1355-1368
        • Walsh BW
        • Schiff I
        • Rosner B
        • Greenberg L
        • Ravnikar V
        • Sacks FM
        Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
        N Engl J Med. 1991; 325: 1196-1204
        • Witztum JL
        • Schonfeld G
        • Weidman SW
        The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
        J Lab Clin Med. 1976; 88: 1008-1018